Transplant surgeon Oscar Salvatierra dies
Oscar Salvatierra founded Stanford’s pediatric kidney transplant program, helped write the national legislation that regulates organ transplants, and conducted research in kidney transplantation.
Mystery novel and dream spur key insight
On Dec. 14, 2014, after many months of not getting expected results, biochemist Jim Spudich got into bed, read a chunk of a novel, fell asleep and had a dream that would change the focus of his entire field in thinking about what causes a common and often lethal heart defect.
Edward Rubenstein dies at 94
Edward Rubenstein was an internist, an educator and an investigator of varied research topics, including synchrotron medical imaging.
Immune cell-based cancer diagnostics
Stanford scientists were able to engineer immune cells known as macrophages to detect and flag cancer in mice. The researchers hope the technique can be used for early cancer diagnostics in humans.
Apple Heart Study demonstrates ability of wearable technology to detect atrial fibrillation
Stanford researchers presented preliminary findings from a virtual study that enrolled more than 400,000 participants.
On the Ides of March, the future is revealed
On March 15, Stanford medical students nervously awaited the moment they could find out where they had matched for their residencies.
Discovery could limit toxic effect of chemo
Stanford researchers have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.
Democracy does wonders for health
The role of democracy in public health leads to dramatic decreases in deaths from noncommunicable diseases, HIV, cardiovascular disease and transportation injuries, according to a new study by researchers at Stanford and several other institutions.
Molecular data categorizes breast cancers
Some breast cancers return decades later. Now, a researcher at Stanford, joined by collaborators at several other institutions, has subcategorized tumors to predict recurrence, guide treatment decisions and improve drug development.
Metabolic profiles of kids
Researchers from throughout Stanford Medicine are planning to study thousands of metabolites in babies, children and pregnant women to understand the origins of disease.